4.6 – References

Augello, Andrea, et al. “Cell Therapy Using Allogeneic Bone Marrow Mesenchymal Stem Cells Prevents Tissue Damage in Collagen-Induced Arthritis.” Arthritis and Rheumatism, vol. 56, no. 4, Apr. 2007, pp. 1175–86. PubMed, doi:10.1002/art.22511.

Chow, Lyndah, et al. “Mechanisms of Immune Suppression Utilized by Canine Adipose and Bone Marrow-Derived Mesenchymal Stem Cells.” Stem Cells and Development, vol. 26, no. 5, 2017, pp. 374–389., doi:10.1089/scd.2016.0207.

Crivelli, Barbara, et al. “Mesenchymal Stem/Stromal Cell Extracellular Vesicles: From Active Principle to next Generation Drug Delivery System.” Journal of Controlled Release, vol. 262, Sept. 2017, pp. 104–17. ScienceDirect, doi:10.1016/j.jconrel.2017.07.023.

DocMikeEvans. Inflammatory Bowel Disease (IBD). YouTube, https://www.youtube.com/watch?v=Keqzt83KMVA. Accessed 3 Dec. 2018.

Duscher, Dominik, et al. “Aging Disrupts Cell Subpopulation Dynamics and Diminishes the Function of Mesenchymal Stem Cells.” Scientific Reports, vol. 4, no. 1, 2014, doi:10.1038/srep07144.

FDA. Approved Cellular and Gene Therapy Products. https://www.fda.gov/biologicsbloodvaccines/cellulargenetherapyproducts/approvedproducts/default.htm. Accessed 1 Dec. 2018.

Frank, Daniel N., et al. “Molecular-Phylogenetic Characterization of Microbial Community Imbalances in Human Inflammatory Bowel Diseases.” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 34, Aug. 2007, pp. 13780–85. PubMed Central, doi:10.1073/pnas.0706625104.

Geremia, Alessandra, et al. “IL-23–Responsive Innate Lymphoid Cells Are Increased in Inflammatory Bowel Disease.” The Journal of Experimental Medicine, vol. 208, no. 6, June 2011, pp. 1127–33. PubMed Central, doi:10.1084/jem.20101712.

Isaacs, Kim L. “How Prevalent Are Extraintestinal Manifestations at the Initial Diagnosis of IBD?” Inflammatory Bowel Diseases, vol. 14, no. suppl_2, Oct. 2008, pp. S198–99. academic-oup-com.myaccess.library.utoronto.ca, doi:10.1002/ibd.20597.

Isakson, M., et al. “Mesenchymal Stem Cells and Cutaneous Wound Healing: Current Evidence and Future Potential.” Stem Cells International, 2015, doi:10.1155/2015/831095.

Henig, Israel, and Tsila Zuckerman. “Hematopoietic Stem Cell Transplantation—50 Years of Evolution and Future Perspectives.” Rambam Maimonides Medical Journal, vol. 5, no. 4, Oct. 2014. PubMed Central, doi:10.5041/RMMJ.10162.

Jiang, Chengyu, et al. “PPAR-γ Agonists Inhibit Production of Monocyte Inflammatory Cytokines.” Nature, vol. 391, no. 6662, Jan. 1998, pp. 82–86. www-nature-com.myaccess.library.utoronto.ca, doi:10.1038/34184.

Johnston, Richard D., and Richard F. A. Logan. “What Is the Peak Age for Onset of IBD?” Inflammatory Bowel Diseases, vol. 14, no. suppl_2, Oct. 2008, pp. S4–5. academic-oup-com.myaccess.library.utoronto.ca, doi:10.1002/ibd.20545.

Kemp, Karen, et al. “Understanding the Health and Social Care Needs of People Living with IBD: A Meta-Synthesis of the Evidence.” World Journal of Gastroenterology : WJG, vol. 18, no. 43, Nov. 2012, pp. 6240–49. PubMed Central, doi:10.3748/wjg.v18.i43.6240.

Liang, Lu, et al. “Human Umbilical Cord Mesenchymal Stem Cells Ameliorate Mice Trinitrobenzene Sulfonic Acid (TNBS)-Induced Colitis.” Cell Transplantation, vol. 20, no. 9, 2011, pp. 1395–1408., doi:10.3727/096368910×557245.

Melton, Douglas. “Chapter 2 – ‘Stemness’: Definitions, Criteria, and Standards.” Essentials of Stem Cell Biology (Third Edition), edited by Robert Lanza and Anthony Atala, Academic Press, 2014, pp. 7–17. ScienceDirect, doi:10.1016/B978-0-12-409503-8.00002-0.

Molodecky, Natalie A., et al. “Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review.” Gastroenterology, vol. 142, no. 1, Jan. 2012, pp. 46-54.e42. ScienceDirect, doi:10.1053/j.gastro.2011.10.001.

Nagaya, Noritoshi, et al. “Transplantation of Mesenchymal Stem Cells Improves Cardiac Function in a Rat Model of Dilated Cardiomyopathy.” Circulation, vol. 112, no. 8, Aug. 2005, pp. 1128–35. PubMed, doi:10.1161/CIRCULATIONAHA.104.500447.

NationwideChildrens. What Is Inflammatory Bowel Disease or IBD? YouTube, https://www.youtube.com/watch?v=Ag0VPruQ96c. Accessed 7 Dec. 2018.

Ng, Siew C., et al. “Environmental Risk Factors in Inflammatory Bowel Disease: A Population-Based Case-Control Study in Asia-Pacific.” Gut, vol. 64, no. 7, July 2015, pp. 1063–71. gut-bmj-com.myaccess.library.utoronto.ca, doi:10.1136/gutjnl-2014-307410.

Nitkin, Christopher R., and Tracey L. Bonfield. “Concise Review: Mesenchymal Stem Cell Therapy for Pediatric Disease: Perspectives on Success and Potential Improvements.” STEM CELLS Translational Medicine, vol. 6, no. 2, 2017, pp. 539–565., doi:10.5966/sctm.2015-0427.

Okita, Keisuke, and Shinya Yamanaka. “Chapter 26 – Induced Pluripotent Stem Cells.” Essentials of Stem Cell Biology (Third Edition), edited by Robert Lanza and Anthony Atala, Academic Press, 2014, pp. 375–85. ScienceDirect, doi:10.1016/B978-0-12-409503-8.00026-3.

Podolsky, D. K., and K. J. Isselbacher. “Glycoprotein Composition of Colonic Mucosa. Specific Alterations in Ulcerative Colitis.” Gastroenterology, vol. 87, no. 5, Nov. 1984, pp. 991–98.

Ranganath, Sudhir H., et al. “Harnessing the Mesenchymal Stem Cell Secretome for the Treatment of Cardiovascular Disease.” Cell Stem Cell, vol. 10, no. 3, Mar. 2012, pp. 244–58. ScienceDirect, doi:10.1016/j.stem.2012.02.005.

Scribano, Maria Lia. “Vedolizumab for Inflammatory Bowel Disease: From Randomized Controlled Trials to Real-Life Evidence.” World Journal of Gastroenterology, vol. 24, no. 23, June 2018, pp. 2457–67. PubMed Central, doi:10.3748/wjg.v24.i23.2457.

Shin, Jin Young, et al. “Mesenchymal Stem Cells Enhance Autophagy and Increase β-Amyloid Clearance in Alzheimer Disease Models.” Autophagy, vol. 10, no. 1, Jan. 2014, pp. 32–44. PubMed Central, doi:10.4161/auto.26508.

Soontararak, Sirikul, et al. “Mesenchymal Stem Cells (MSC) Derived from Induced Pluripotent Stem Cells (IPSC) Equivalent to Adipose-Derived MSC in Promoting Intestinal Healing and Microbiome Normalization in Mouse Inflammatory Bowel Disease Model.” STEM CELLS Translational Medicine, vol. 7, no. 6, June 2018, pp. 456–67. Wiley Online Library, doi:10.1002/sctm.17-0305.

TED-Ed. What Are Stem Cells? – Craig A. Kohn. YouTube, https://www.youtube.com/watch?v=evH0I7Coc54. Accessed 7 Dec. 2018.

Theise, Neil, and Swenson. “Stem Cell Therapeutics: Potential in the Treatment of Inflammatory Bowel Disease.” Clinical and Experimental Gastroenterology, 2010, p. 1., doi:10.2147/ceg.s6836.

Torres, Joana, et al. “Crohn’s Disease.” The Lancet, vol. 389, no. 10080, Apr. 2017, pp. 1741–55. ScienceDirect, doi:10.1016/S0140-6736(16)31711-1.

Ungaro, Ryan, et al. “Ulcerative Colitis.” The Lancet, vol. 389, no. 10080, Apr. 2017, pp. 1756–70. ScienceDirect, doi:10.1016/S0140-6736(16)32126-2.

Wehkamp, J., et al. “NOD2 (CARD15) Mutations in Crohn’s Disease Are Associated with Diminished Mucosal α-Defensin Expression.” Gut, vol. 53, no. 11, Nov. 2004, pp. 1658–64. PubMed Central, doi:10.1136/gut.2003.032805.

What Are Crohn’s and Colitis? – Crohn’s and Colitis Canada. http://www.crohnsandcolitis.ca/About-Crohn-s-Colitis/What-are-Crohns-and-Colitis?gclid=EAIaIQobChMIg66pyuDw3gIVTIGzCh1q7AEEEAAYASAAEgIJP_D_BwE. Accessed 26 Nov. 2018.